• Hepatocellular carcinoma
  • C-Reactive Protein (CRP)
  • Amiodarone, Serum
  • ToRCH Panel, IgG
  • Human Chorionic Gonadotropin (hCG), Quantitative, Serum
  • Osmolality, Serum
  • Electron Microscopy
  • Aspergillus fumigatus, IgE
  • Hexosaminidase A (HEXA) Gene Mutation Analysis
  • HIV-1 Genotyping and Tropism by Next Generation Sequencing (DEEPGEN)
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /BCR-ABL Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

BCR-ABL Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
Medical Test

Additional ICD10
Access to BCR-ABL Mutation Analysis for Tyrosine Kinase Inhibitor Resistance is restricted.